Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.58 USD | +1.03% | +6.94% | +18.36% |
Financials (USD)
Sales 2024 * | 4.49B | Sales 2025 * | 4.69B | Capitalization | 8.6B |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | 52M | EV / Sales 2024 * | 2.98 x |
Net Debt 2024 * | 4.77B | Net Debt 2025 * | 4.28B | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
-414
x | P/E ratio 2025 * |
73
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | +1.52% | ||
1 week | +2.78% | ||
Current month | +32.22% | ||
1 month | +28.22% | ||
3 months | +9.50% | ||
6 months | +44.76% | ||
Current year | +16.78% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 254 M€ | +12.63% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 17 M€ | +5.88% | - | |
0.33% | 2 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 17.64 | +1.35% | 2 424 222 |
24-05-29 | 17.4 | +1.52% | 6,041,537 |
24-05-28 | 17.14 | +2.08% | 5,372,094 |
24-05-24 | 16.79 | +1.82% | 3,042,322 |
24-05-23 | 16.49 | -2.60% | 3,275,998 |
Delayed Quote Nyse, May 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.78% | 8.6B | |
-13.46% | 77.94B | |
+24.50% | 3.68B | |
+12.16% | 1.61B | |
-11.61% | 1.47B | |
-1.17% | 1.3B | |
-24.87% | 1.26B | |
-16.73% | 1.09B | |
-5.61% | 987M | |
-4.36% | 879M |
- Stock Market
- Equities
- ELAN Stock